200
Participants
Start Date
October 15, 2024
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2026
enavogliflozin 0.3mg
"Enavogliflozin 0.3mg, 1 tablet once a day, is prescribed for a period of 24 weeks.~Patients who are eligible for all of the criteria and who do not qualify as exclusion criteria should be enrolled in the study and randomly enrolled in a 1: 1 dose of enavogliflozin 0.3 mg once daily or placebo."
enavogliflozin Placebo
"A placebo pill identical to enavogliflozin, 1 tablet once a day, is prescribed for a period of 24 weeks.~Patients who are eligible for all of the criteria and who do not qualify as exclusion criteria should be enrolled in the study and randomly enrolled in a 1: 1 dose of enavogliflozin 0.3 mg once daily or placebo."
RECRUITING
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul
Yonsei University
OTHER